These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37355438)

  • 81. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 82. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Outbreak news.Ebola, Uganda.
    Wkly Epidemiol Rec; 2011 May; 86(22):221. PubMed ID: 21661270
    [No Abstract]   [Full Text] [Related]  

  • 84. Infection control during filoviral hemorrhagic fever outbreaks: preferences of community members and health workers in Masindi, Uganda.
    Raabe VN; Mutyaba I; Roddy P; Lutwama JJ; Geissler W; Borchert M
    Trans R Soc Trop Med Hyg; 2010 Jan; 104(1):48-50. PubMed ID: 19783269
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ebola virus disease outbreak - Nigeria, July-September 2014.
    Shuaib F; Gunnala R; Musa EO; Mahoney FJ; Oguntimehin O; Nguku PM; Nyanti SB; Knight N; Gwarzo NS; Idigbe O; Nasidi A; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Oct; 63(39):867-72. PubMed ID: 25275332
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ebola outbreak in Uganda: patient values and preferences.
    Okamoto F; Nishikawa Y; Twalla Y; Nakayama T; Masai S
    Lancet; 2022 Dec; 400(10367):1925-1926. PubMed ID: 36463903
    [No Abstract]   [Full Text] [Related]  

  • 87. WHO ready to deploy Ebola vaccine in disease outbreak.
    Gulland A
    BMJ; 2017 May; 357():j2454. PubMed ID: 28533207
    [No Abstract]   [Full Text] [Related]  

  • 88. The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school.
    Bitekyerezo M; Kyobutungi C; Kizza R; Mugeni J; Munyarugero E; Tirwomwe F; Twongyeirwe E; Muhindo G; Nakibuuka V; Nakate M; John L; Ruiz A; Frame K; Priotto G; Pepper L; Kabakyenga J; Baingana S; Ledo D
    Trop Doct; 2002 Jan; 32(1):10-5. PubMed ID: 11991014
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Role of Community Beliefs and Practices on the Spread of Ebola in Uganda, September 2022.
    Naiga HN; Zalwango JF; Agaba B; Kizito SN; Simbwa BN; Zalwango MG; Akunzirwe R; Kabami Z; Kawugenzi PC; Zavuga R; Ninsiima M; King P; Wanyana MW; Kiggundu T; Migisha R; Gonahasa D; Kyamwine I; Kwesiga B; Kadobera D; Bulage L; Riolexus AA; Paige SB; Harris JR
    J Epidemiol Glob Health; 2024 Oct; ():. PubMed ID: 39382758
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Vaccines against Ebola virus.
    Venkatraman N; Silman D; Folegatti PM; Hill AVS
    Vaccine; 2018 Aug; 36(36):5454-5459. PubMed ID: 28780120
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Challenges and opportunities for China entering global research and development for emerging infectious diseases: a case study from Ebola experience.
    Li C; Chen JY; Huang YM
    Infect Dis Poverty; 2020 Mar; 9(1):27. PubMed ID: 32164743
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Considerations for use of Ebola vaccine during an emergency response.
    Walldorf JA; Cloessner EA; Hyde TB; MacNeil A;
    Vaccine; 2019 Nov; 37(48):7190-7200. PubMed ID: 28890191
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
    Mbala-Kingebeni P; Villabona-Arenas CJ; Vidal N; Likofata J; Nsio-Mbeta J; Makiala-Mandanda S; Mukadi D; Mukadi P; Kumakamba C; Djokolo B; Ayouba A; Delaporte E; Peeters M; Muyembe Tamfum JJ; Ahuka-Mundeke S
    Clin Infect Dis; 2019 Jan; 68(2):330-333. PubMed ID: 29961823
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: A state of arts review.
    Abdul-Rahman T; Lawal L; Meale E; Ajetunmobi OA; Toluwalashe S; Alao UH; Ghosh S; Garg N; Aborode AT; Wireko AA; Mehta A; Sikora K
    J Med Virol; 2023 Aug; 95(8):e28986. PubMed ID: 37534818
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Ebola hemorrhagic fever: its extension reflects the African sanitary disaster].
    Bourée P
    Rev Prat; 2014 Sep; 64(7):905-10. PubMed ID: 25362763
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.
    MacNeil A; Farnon EC; Wamala J; Okware S; Cannon DL; Reed Z; Towner JS; Tappero JW; Lutwama J; Downing R; Nichol ST; Ksiazek TG; Rollin PE
    Emerg Infect Dis; 2010 Dec; 16(12):1969-72. PubMed ID: 21122234
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Establishment of a research pharmacy to support Ebola clinical research in Liberia.
    Pierson JF; Kirchoff MC; Tyee RT; Montello MJ; Rhie JK
    J Am Pharm Assoc (2003); 2017; 57(4):542-546. PubMed ID: 28610940
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Strengthening the maternal and child health responses to Ebola outbreaks in Uganda.
    Chowdhury M; Ouma J; Nakabembe E; Mwanga-Amumpaire J; Kirenga B; Bosa HK; Wayengera M; Le Doare K; Sekikubo M
    Lancet Infect Dis; 2023 Jun; 23(6):650-651. PubMed ID: 37105213
    [No Abstract]   [Full Text] [Related]  

  • 100. [Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra Leone].
    Watanabe T; Kawaoka Y
    Uirusu; 2016; 66(1):53-62. PubMed ID: 28484179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.